Dementia in Parkinson's disease

Dementia as a manifestation of idiopathic PD is an important feature of the disease in terms of QOL, prognosis, and clinical management. The pathophysiology of the disorder is likely a multifactorial process that encompasses derangement of multiple neuronal populations of both subcortical and cortical origin. This process results in a cognitive profile that largely reflects a dysexecutive syndrome. Currently, treatment of PDD is symptomatic. Further research is needed to elucidate the relationship of PDD to DLB and AD in hopes of developing and using appropriate therapeutic measures designed to address the underlying disease process.

[1]  Wilder Penfield,et al.  THE EVIDENCE FOR A CEREBRAL VASCULAR MECHANISM IN EPILEPSY , 1933 .

[2]  R. S. Stacey,et al.  5‐hydroxytryptamine in normal human platelets , 1955, The Journal of physiology.

[3]  F. Sicuteri,et al.  Biochemical Investigations in Headache: Increase in the Hydroxyindoleacetic Acid Excretion During Migraine Attacks , 1961 .

[4]  R. Connor,et al.  Complicated migraine. A study of permanent neurological and visual defects caused by migraine. , 1962, Lancet.

[5]  S. M. Sumi,et al.  Focal seizures , 1963, Neurology.

[6]  J. Lance,et al.  Plasma serotonin in migraine and stress. , 1967, Archives of neurology.

[7]  F Plum,et al.  Cerebral metabolic and circulatory responses to induced convulsions in animals. , 1968, Archives of neurology.

[8]  F. Plum,et al.  Cerebral metabolism during electrically-induced seizures in man. , 1969, Transactions of the American Neurological Association.

[9]  A. Lorenzo,et al.  Temporary alteration of cerebrovascular permeability to plasma protein during drug-induced seizures. , 1972, The American journal of physiology.

[10]  D. Devivo,et al.  Positive brain scans in children with idiopathic focal epileptic seizures , 1973, Neurology.

[11]  O B Paulson,et al.  Cerebral hyperemia in electrically induced epileptic seizures. , 1973, Archives of neurology.

[12]  J. Stears,et al.  Focal seizures, early veins, and increased flow , 1974, Neurology.

[13]  D. Holmquest,et al.  Abnormal scintiangiographic findings associated with seizure activity. , 1974, Radiology.

[14]  J. Meyer,et al.  Cyclic Changes in Platelet Dynamics and the Pathogenesis and Prophylaxis of Migraine , 1977, Headache.

[15]  H. Goldberg,et al.  Hypervascular pattern associated with idiopathic focal status epilepticus. , 1977, Radiology.

[16]  馬渡 志郎.  Adenyl cyclase abnormality in Duchenne muscular dystrophy : muscle cells in culture , 1977 .

[17]  M. Gawel,et al.  The Platelet Release Reaction During Migraine Attacks , 1979, Headache.

[18]  P. Steele,et al.  Platelet Survival Time and Thromboembolism in Patients with Mitral Valve Prolapse , 1979, Circulation.

[19]  H. Balfour,et al.  Virus‐associated hemophagocytic syndrome A benign histiocytic proliferation distinct from malignant histiocytosis , 1979, Cancer.

[20]  G. Rice,et al.  Familial stroke syndrome associated with mitral valve prolapse , 1980, Annals of neurology.

[21]  H. Barnett,et al.  Further evidence relating mitral-valve prolapse to cerebral ischemic events. , 1980, The New England journal of medicine.

[22]  J. Fasules,et al.  Transient positive postictal computed tomographic scan. , 1980, The Journal of pediatrics.

[23]  P. Walsh,et al.  Platelets, Thromboembolism and Mitral Valve Prolapse , 1981, Circulation.

[24]  J. Lueck,et al.  Cerebral ischemia in young patients: it is associated with mitral valve prolapse and abnormal platelet activity in vivo? , 1982, Stroke.

[25]  I. Zeeberg,et al.  Changes in platelet function and blood serotonin level in migraine patients during treatment with femoxetine , 1982, Acta neurologica Scandinavica.

[26]  C. Nitsch,et al.  Regional patterns of blood-brain barrier breakdown during epileptiform seizures induced by various convulsive agents , 1983, Journal of the Neurological Sciences.

[27]  I. Ockene,et al.  Platelet activation and mitral valve prolapse , 1983, Neurology.

[28]  W. Dillon,et al.  Transient computed tomographic abnormalities after focal seizures. , 1984, AJNR. American journal of neuroradiology.

[29]  K P Offord,et al.  Epidemiology of parkinsonism: Incidence, classification, and mortality , 1984, Annals of neurology.

[30]  P. Nichol,et al.  Increased prevalence of mitral valve prolapse in patients with migraine. , 1984, Canadian Medical Association journal.

[31]  F. Andermann,et al.  Prolonged Focal Cerebral Edema Associated with Partial Status Epilepticus , 1985, Epilepsia.

[32]  W. Wright.  Myoblast senescence in muscular dystrophy. , 1985, Experimental cell research.

[33]  P. Sethi,et al.  Appearing and disappearing CT scan abnormalities and seizures. , 1985, Journal of neurology, neurosurgery, and psychiatry.

[34]  P. K. Mohan,et al.  Transient computerised tomographic (CT) abnormalities following partial seizures , 1985, Acta neurologica Scandinavica.

[35]  R. Uitti,et al.  Early Onset Parkinson's Disease in Saskatchewan - Environmental Considerations for Etiology , 1986, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[36]  B. Nadal-Ginard,et al.  There types of muscle-specific gene expression in fusion-blocked rat skeletal muscle cells: Translational control in EGTA-treated cells , 1987, Cell.

[37]  H. Lüders,et al.  Transient Focal Abnormalities of Neuroimaging Studies During Focal Status Epilepticus , 1987, Epilepsia.

[38]  J. Caroscio,et al.  Amyotrophic lateral sclerosis. Its natural history. , 1987, Neurologic clinics.

[39]  R. Goulatia,et al.  Disappearing CT Lesions in Epilepsy , 1987, Epilepsia.

[40]  G. V. van Melle,et al.  Migraine stroke , 1988, Neurology.

[41]  R. Brown,et al.  Prednisone therapy for Duchenne's muscular dystrophy. , 1989, The New England journal of medicine.

[42]  S. Milstien,et al.  Tetrahydrobiopterin, the cofactor for aromatic amino acid hydroxylases, is synthesized by and regulates proliferation of erythroid cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[43]  J. Miller,et al.  Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. , 1989, The New England journal of medicine.

[44]  R. Price,et al.  Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection , 1990, Annals of neurology.

[45]  M. Brčić,et al.  Effect of IgG for intravenous use on Fc receptor‐mediated phagocytosis by human monocytes , 1990, Clinical and experimental immunology.

[46]  S. Appel,et al.  IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. , 1990, Archives of neurology.

[47]  J. Mendell,et al.  Mononuclear cell analysis of muscle biopsies in prednisone‐treated and untreated Duchenne muscular dystrophy , 1991, Neurology.

[48]  R. Edwards,et al.  Enhanced lipid peroxidation in Duchenne dystrophy muscle may be secondary to muscle damage. , 1991, Biochemical Society Transactions.

[49]  R. Sklar,et al.  Methylprednisolone increases dystrophin levels by inhibiting myotube death during myogenesis of normal human muscle in vitro , 1991, Journal of the Neurological Sciences.

[50]  A. C. Bragdon,et al.  MRI reveals multiple reversible cerebral lesions in an attack of acute intermittent porphyria , 1991, Neurology.

[51]  E. Werner,et al.  Neopterin as a marker for activated cell-mediated immunity: application in malignant disease. , 1991, Cancer detection and prevention.

[52]  E. Hall,et al.  The neuroprotective pharmacology of methylprednisolone. , 1992, Journal of neurosurgery.

[53]  D. Protti,et al.  Long-term neuromuscular dysfunction produced by passive transfer of amyotrophic lateral sclerosis immunoglobulins , 1992, Neurology.

[54]  D. Leroith,et al.  Insulin-like Growth Factors in Health and Disease , 1992 .

[55]  L. Austin,et al.  Potential oxyradical damage and energy status in individual muscle fibres from degenerating muscle diseases , 1992, Neuromuscular Disorders.

[56]  J. Remacle,et al.  The importance of antioxidant enzymes in cellular aging and degeneration. , 1992, EXS.

[57]  O. Hardiman,et al.  Direct effects of cyclosporin A and cyclophosphamide on differentiation of normal human myoblasts in culture , 1993, Neurology.

[58]  S Noachtar,et al.  Expanding the International Classification of Seizures to provide localization information , 1993, Neurology.

[59]  O. Hardiman,et al.  Methylprednisolone selectively affects dystrophin expression in human muscle cultures , 1993, Neurology.

[60]  Robert G. Miller,et al.  Cyclosporine increases muscular force generation in Duhenne muscular dystrophy , 1993, Neurology.

[61]  M. Brooke,et al.  Mononuclear cell analysis of muscle biopsies in prednisone‐ and azathioprine‐treated Duchenne muscular dystrophy , 1993, Neurology.

[62]  T. Deloughery,et al.  Natural killer cell leukemia presenting with a peripheral neuropathy , 1993, Neurology.

[63]  J. Hubble,et al.  Risk factors for Parkinson's disease , 1993, Neurology.